Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-specific T cell expansion.
Le Gall C, Cammarata A, de Haas L, Ramos-Tomillero I, Cuenca-Escalona J, Schouren K, Wijfjes Z, Becker AMD, Bödder J, Dölen Y, de Vries IJM, Figdor CG, Flórez-Grau G, Verdoes M. Le Gall C, et al. Among authors: cammarata a. J Immunother Cancer. 2022 Apr;10(4):e004309. doi: 10.1136/jitc-2021-004309. J Immunother Cancer. 2022. PMID: 35428705 Free PMC article.
Dual Site-Specific Chemoenzymatic Antibody Fragment Conjugation Using CRISPR-Based Hybridoma Engineering.
Le Gall CM, van der Schoot JMS, Ramos-Tomillero I, Khalily MP, van Dalen FJ, Wijfjes Z, Smeding L, van Dalen D, Cammarata A, Bonger KM, Figdor CG, Scheeren FA, Verdoes M. Le Gall CM, et al. Among authors: cammarata a. Bioconjug Chem. 2021 Feb 17;32(2):301-310. doi: 10.1021/acs.bioconjchem.0c00673. Epub 2021 Jan 21. Bioconjug Chem. 2021. PMID: 33476135 Free PMC article.
Antibody-mediated protection against symptomatic COVID-19 can be achieved at low serum neutralizing titers.
Schmidt P, Narayan K, Li Y, Kaku CI, Brown ME, Champney E, Geoghegan JC, Vásquez M, Krauland EM, Yockachonis T, Bai S, Gunn BM, Cammarata A, Rubino CM, Ambrose P, Walker LM. Schmidt P, et al. Among authors: cammarata a. Sci Transl Med. 2023 Mar 22;15(688):eadg2783. doi: 10.1126/scitranslmed.adg2783. Epub 2023 Mar 22. Sci Transl Med. 2023. PMID: 36947596 Free article.
Antibody-mediated protection against symptomatic COVID-19 can be achieved at low serum neutralizing titers.
Schmidt P, Narayan K, Li Y, Kaku C, Brown M, Champney E, Geoghegan J, Vasquez M, Krauland E, Yockachonis T, Bai S, Gunn B, Cammarata A, Rubino C, Walker LM. Schmidt P, et al. Among authors: cammarata a. medRxiv [Preprint]. 2022 Oct 19:2022.10.18.22281172. doi: 10.1101/2022.10.18.22281172. medRxiv. 2022. PMID: 36299436 Free PMC article. Updated. Preprint.
Author Correction: Antineoplastic activity of products derived from cellulose‑containing materials: levoglucosenone and structurally‑related derivatives as new alternatives for breast cancer treatment.
Delbart DI, Giri GF, Cammarata A, Pan MD, Bareño LA, Amigo NL, Bechis A, Suarez AG, Spanevello RÁ, Villaverde MS, Todaro LB, Urtreger AJ. Delbart DI, et al. Among authors: cammarata a. Invest New Drugs. 2022 Feb;40(1):42. doi: 10.1007/s10637-021-01200-8. Invest New Drugs. 2022. PMID: 34843006 No abstract available.
Phototribology: Control of Friction by Light.
Perotti BL, Cammarata A, Cemin F, Sales de Mello SR, Leidens LM, Echeverrigaray FG, Minea T, Alvarez F, Michels AF, Polcar T, Figueroa CA. Perotti BL, et al. Among authors: cammarata a. ACS Appl Mater Interfaces. 2021 Sep 15;13(36):43746-43754. doi: 10.1021/acsami.1c13054. Epub 2021 Sep 7. ACS Appl Mater Interfaces. 2021. PMID: 34491711
90 results